BellentaniS., 2017.The epidemiology of non‐alcoholic fatty liver disease,Liver Int 37 81 -84
Yki-Järvinen H, 2016.Diagnosis of non-alcoholic fatty liver disease (NAFLD),Diabetologia 59 1104 -11
LazoM,HernaezR,EberhardtMS,BonekampS,KamelI,GuallarE, 2013.Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey,, 178 38 -45
SzczepaniakLS,NurenbergP,LeonardD,BrowningJD,ReingoldJS,GrundyS, 2005.Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population,Am J Physiol Endocrinol Metab 288 E462 -8
LoombaR,SanyalAJ, 2013.The global NAFLD epidemic,Nat Rev Gastroenterol Hepatol 10 686 -
BirkenfeldAL,ShulmanGI, 2014.Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes,Hepatol 59 713 -23
GanzM,SzaboG, 2013.Immune and inflammatory pathways in NASH,Hepatol int 7 771 -81
SchwengerKJ,AllardJP., 2014.Clinical approaches to nonalcoholic fatty liver disease,Worl j gastroenterol: WJG 20 1712 -
Portillo-SanchezP,BrilF,MaximosM,LomonacoR,BiernackiD,OrsakB, 2015.High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels,J Clin Endocrinol Metab 100 2231 -38
CusiK., 2012.Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications,Gastroenterol 142 711 -25
TolmanKG,FonsecaV,DalpiazA,TanMH, 2007.Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease,Diabetes Care 30 734 -43
TargherG,MantovaniA,PichiriI,MingollaL,CavalieriV,MantovaniW, 2014.Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes,Diabetes Care 37 1729 -36
TargherG,MarraF,MarchesiniG, 2008.Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?,Diabetologia 51 1947 -53
VillanovaN,MoscatielloS,RamilliS,BugianesiE,MagalottiD,VanniE, 2005.Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease,Hepatol 42 473 -80
ParkSK,SeoMH,ShinHC,RyooJH., 2013.Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5‐year prospective cohort study,Hepatol 57 1378 -83
BaeJC,RheeEJ,LeeWY,ParkSE,ParkCY,OhKW, 2011.Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study,Diabetes Care 34 727 -29
RyanCK,JohnsonLA,GerminBI,MarcosA, 2002.One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation,Liver transplant 8 1114 -22
FracanzaniAL,ValentiL,BugianesiE,AndreolettiM,ColliA,VanniE, 2008.Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes,Hepatol 48 792 -98
MofradP,ContosMJ,HaqueM,SargeantC,FisherRA,LuketicVA, 2003.Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values,Hepatol 37 1286 -92